GLP-1 drugs suppress appetite primarily through vagus nerve signaling from the gut, but their brain penetration and effects on cognition are still debated.
2
Early-life consumption of artificial sweeteners (within FDA limits) in rodents led to lasting memory impairments and glucose dysregulation, though human evidence is mixed.
3
Diet high in sugar or processed foods during development causes long-term hippocampal memory deficits that persist even after switching to healthy diet; exercise can rescue some deficits.
4
The gut-brain axis via vagus nerve and acetylcholine release in hippocampus is crucial for encoding memories of eating occasions, and may be hijacked by hyper-palatable foods.
Protocols
Concrete recipes — what, when, how much, and why
1 item
Self-experimentation with eating patterns
WhatExperiment with different meal frequencies (e.g., three meals vs. grazing vs. one meal a day) to find what optimizes your cognitive function and energy.
WhenOngoing; adjust based on personal response.
DoseNo specific dose; try each pattern for at least a week.
For whomAnyone seeking to optimize cognitive performance.
WhyIndividual differences in how eating timing affects focus and memory; no one-size-fits-all.
CaveatsEnsure adequate nutrient intake regardless of pattern.
Dr. Kanoski notes that his students have varied eating patterns and likely fall into what works for them naturally. He suggests self-experimentation rather than following a prescribed schedule.
I don't think there's one recipe for when should you eat, how many times a day, how much... worth doing some self-experimentation for people.
What's new
Personal practice updates, fresh positions, predictions
8 items
GLP-1 brain penetration controversy
around 10-15 minutes
Whether newer GLP-1 drugs like Wegovy enter the brain is unclear; older drugs did, but newer ones may act primarily at circumventricular organs or via vagus nerve.
Why this matters: Contradicts popular assumption that these drugs work directly on brain reward centers.
Background
Early GLP-1 drugs (2005-2012) showed brain action; newer generation less clear.
Dr. Kanoski explains that fluorescent tagging studies are confounded by autofluorescence and fading. Radio-labeling studies (carbon-14) by Elizabeth Rhea and Bill Banks suggest older drugs readily enter brain, newer ones less so. The vagus nerve is a key peripheral pathway for native GLP-1, but long-acting drugs may have different kinetics. This has implications for off-label cognitive benefits.
Whether these newer generation GLP-1 drugs like Wegovy are getting into the brain is less clear. Really again controversial.
Also said
“There's a school of thought that these drugs are acting primarily in those circumventricular organs but those studies are tricky because fluorescent molecules fade and the brain has autofluorescent signal.”— Explains methodological challenges.
“The jury is still out. Where they're getting into the brain is not something we have a clear understanding of at this point.”— Emphasizes uncertainty.
Vagus nerve essential for GLP-1 appetite suppression
around 15-20 minutes
Selective lesion of sensory vagus nerve abolishes food intake reduction from native GLP-1, but not long-acting drugs.
Why this matters: Highlights peripheral mechanism vs central.
Background
Vagus nerve innervates GI tract; GLP-1 acts paracrine on vagal terminals.
Dr. Kanoski describes work from Wolfgang Langhans showing that vagal lesion blocks native GLP-1 effect. Also RNA interference knockdown of GLP-1 receptors on vagus leads to larger meals. This supports the idea that physiological GLP-1 signals satiation via vagus to brainstem.
If you do a selective lesion to the sensory vagus nerve as it comes up from the GI tract to the brain and then inject GLP-1, it's not effective in reducing food intake.
Also said
“They also knock down using short hairpin RNA interference... those animals have a phenotype, right? So they eat more. They have larger meals.”— Confirms causal role.
Artificial sweeteners during development impair memory and glucose regulation in rodents
around 25-30 minutes
Juvenile rats given daily artificial sweeteners (stevia, Ace-K, saccharine) within FDA acceptable intake showed adult memory deficits and altered insulin response.
Why this matters: Suggests potential long-term neurocognitive risks, even with 'safe' doses.
Background
Three camps of opinion; preclinical evidence mixed.
Dr. Kanoski's lab gave rats voluntary consumption of sweeteners during juvenile/adolescent stage. As adults, they performed at chance on hippocampal memory tasks, had larger insulin spikes to glucose infusion, and changes in sweet taste receptor expression on tongue. Effects were similar across three sweeteners. Caveat: rodent model, not human.
We found that the animals had some memory impairments, which was an unexpected finding. We don't really know the mechanism for that.
Also said
“We used three different sweeteners and it didn't seem to matter which one we used.”— Suggests class effect.
Memory of recent meal influences subsequent eating
around 35-40 minutes
Priming people to remember a recent lunch reduced cookie consumption; manipulating perceived volume of soup affected later hunger ratings.
Why this matters: Demonstrates that memory, not just physiological fullness, guides eating behavior.
Background
Studies by Suzanne Higgs and Jeff Brunstrom.
Higgs study: participants primed to remember pizza lunch ate fewer cookies later. Brunstrom study: hidden pump changed soup volume; immediate hunger based on actual intake, but hours later hunger based on perceived intake. This shows memory of meal plays a role in satiety over time.
If they were primed to remember the lunch they had just consumed, they consumed fewer of these biscuits or cookies.
Also said
“A couple hours later that flipped and their hunger ratings were more driven by what they saw, what they think they consumed versus what they actually consumed.”— Shows time-dependent shift.
Early-life high sugar diet causes persistent hippocampal memory deficits
around 40-45 minutes
Rats given sugar solution (equivalent to soft drink) during development showed lasting memory impairments even after switching to healthy diet.
Why this matters: Implicates developmental sugar exposure in long-term cognitive decline.
Background
Adult models show deficits after weeks; developmental model shows persistence.
Dr. Kanoski's lab gave ad libitum sugar solution (similar calorie percentage to soda) plus healthy chow. Animals later had hippocampal-dependent memory deficits that persisted into adulthood despite no further sugar. Microbiome changes may be involved. Similar results with junk food diet (chocolate, chips).
The animals show hippocampal dependent memory deficits when they're older. And these seem to persist later into life even though they're not consuming the sugar anymore.
Also said
“We've also looked at models where the animals are consuming like a total junk food diet... they show these memory impairments that last even after you switch them to a healthy diet.”— Extends to junk food.
Heat-treated food (Maillard reaction) induces memory impairments via microbiome changes
around 50-55 minutes
Rats fed otherwise healthy food that was baked to induce advanced glycation end products (AGEs) showed memory deficits; reintroducing a specific bacterium (Lactobacillus) rescued them.
Why this matters: Identifies a specific dietary processing variable (heat) and a bacterial target for rescue.
Background
NOVA classification not mechanistic; Dr. Kanoski's lab isolated heat treatment.
Preprint study: healthy food baked at high temperature to create Maillard reaction and AGEs. Animals fed this during development had memory impairments. A population of lactic acid bacteria was eliminated; reintroducing it reversed deficits. This suggests that food processing can affect cognition via gut microbiome.
We see memory impairments with this AGE-enriched diet. We think that there may be a role for the microbiome... when we reintroduced it to the animals we were able to reverse these memory impairments.
Also said
“There was a population of bacteria that was eliminated through the heat treatment process.”— Identifies mechanism.
Acetylcholine release in hippocampus during eating encodes meal memory
around 60-65 minutes
Using fiber photometry, Dr. Kanoski's lab found that acetylcholine levels in hippocampus ramp up during eating and remain elevated post-meal, likely to consolidate memory of the eating episode.
Why this matters: Direct neural correlate of how gut signals influence memory.
Acetylcholine levels increase in a staircase pattern during meal, with baseline higher after meal. This postprandial elevation is thought to help animals remember where and what they ate. Taste alone (stevia) does not trigger this; requires combination of taste and post-oral nutrients.
We think that that elevated postprandial level of acetylcholine in hippocampus is to allow the animals to remember what the hell's going on... just ate this meal. Where am I? Can I get back here and do this again?
Also said
“If the animals consume stevia a non-nutritive sweetener, we don't see that the acetylcholine release patterns in the hippocampus.”— Shows nutrient dependence.
Oxytocin's dual role in feeding: reduces intake via brainstem but promotes social eating via hippocampus
around 70-75 minutes
Oxytocin typically reduces meal size via brainstem, but in hippocampus it mediates social facilitation of eating (eating more with familiar others).
Why this matters: Reveals context-dependent effects of same neuromodulator.
Background
Known anorexigenic effects; new findings show hippocampal oxytocin promotes intake in social settings.
Dr. Kanoski's lab genetically knocked down oxytocin signaling in hippocampus; animals no longer showed increased eating when with familiar cage mates. This suggests oxytocin in hippocampus integrates social context to override typical satiety signals.
We found that that phenomenon requires oxytocin signaling in the hippocampus. So if we genetically turn down the signal, the animals don't show that effect.
Also said
“Historically it's been unidirectional that oxytocin in the brain reduces food intake. But some recent findings... it might depend on the social context.”— Highlights complexity.
Notable quotes
Lines worth pulling out — contrarian, specific, or perfectly phrased
6 items
Whether these newer generation GLP-1 drugs like Wegovy are getting into the brain is less clear. Really again controversial.
Captures the central uncertainty about mechanism of action for popular weight-loss drugs.
We think that that elevated postprandial level of acetylcholine in hippocampus is to allow the animals to remember what the hell's going on... just ate this meal. Where am I? Can I get back here and do this again?
Vividly explains the evolutionary purpose of gut-brain memory encoding.
If you do a selective lesion to the sensory vagus nerve as it comes up from the GI tract to the brain and then inject GLP-1, it's not effective in reducing food intake.
Key experimental evidence for vagal mediation of GLP-1 effects.
We found that the animals had some memory impairments, which was an unexpected finding. We don't really know the mechanism for that.
Honest admission of uncertainty in a controversial area (artificial sweeteners).
There does seem to be in one small study a positive correlation so there may be some risk factor for vagotomy in humans and developing Alzheimer's.
Links a historical medical procedure to dementia risk, opening new research avenues.
I don't think there's one recipe for when should you eat, how many times a day, how much... worth doing some self-experimentation for people.
Practical takeaway for listeners seeking personalized nutrition advice.
Sign in to share feedback
Tell us if this brief hit the mark or missed it — feedback feeds back into the next iteration of the prompt.
Reading is free for everyone. A free account adds the personal layer: save protocols, follow experts, and see how the other experts weigh in on this same topic.
Educational summary of the cited expert source — not medical advice. Open the source recording linked above and consult a qualified physician before acting on any protocol.
